Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99.3M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
101K
-
Shares change
-
-39K
-
Total reported value, excl. options
-
$182K
-
Value change
-
-$69.2K
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$1.81
Significant Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) as of Q1 2024
12 filings reported holding PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value as of Q1 2024.
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101K shares
of 99.3M outstanding shares and own 0.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (32.5K shares), GEODE CAPITAL MANAGEMENT, LLC (29.3K shares), RENAISSANCE TECHNOLOGIES LLC (17.4K shares), CITADEL ADVISORS LLC (10.7K shares), BlackRock Inc. (6.96K shares), Tower Research Capital LLC (TRC) (3.83K shares), OSAIC HOLDINGS, INC. (133 shares), JPMORGAN CHASE & CO (100 shares), WELLS FARGO & COMPANY/MN (35 shares), and GROUP ONE TRADING, L.P. (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.